Newly discovered drug may reverse pulmonary arterial hypertension (PAH), reports a new study. The findings of the study are published in the American Journal of Respiratory Critical Care Medicine ...

Pulmonary arterial hypertension (PAH) is a vascular remodeling disease that pathologically increases pulmonary vascular resistance. Ultimately, this leads to right ventricular failure and ...

An emerging strategy for targeted therapy of pulmonary arterial hypertension: Vasodilation plus vascular remodeling inhibition. Drug Discov Today . Published online January 29, 2022. doi:10.1016/j ...

Medindia » Hypertension News. Novel Target for Pulmonary Hypertension Identified. by Sheela Philomena on October 18, 2011 at 3:14 PM. Facebook; Twitter; Pinterest; Linkedin; ...

Novel Treatment For Chronic Hypoxic Pulmonary Hypertension (PHTN). ScienceDaily . Retrieved May 7, 2025 from www.sciencedaily.com / releases / 2009 / 02 / 090223124215.htm ...

Hypertension Research - Novel insight into ... and treatment of acute and chronic heart failure’, 13 there are innovative and new therapeutics on the horizon that target reverse remodeling at ...

DelveInsight’s pulmonary hypertension pipeline report depicts a robust space with 80+ active players working to develop 80+ pipeline therapies for pulmonary hypertension treatmentNew York, USA ...

Pulmonary hypertension, despite advances in treatment, still has a poor prognosis, which is often associated with right heart failure, and for which pulmonary arterial hypertension (PAH) is a severe ...

Pulmonary hypertension is a highly lethal disease that transforms the thin, flexible vasculature of the lungs into thick, dysfunctional blood vessels that can kill. Topics. Conditions.

Expert Rev Resp Med. 2013;7(1):43-55. The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the ...